Chronic underdosing could mean you plateau below your target weight or don't achieve adequate blood sugar control
See our San Antonio Semaglutide & Tirzepatide program with InBody tracking, labs, and face-to-face physician care
Months 2 to 3: This is where the FDAs 12-week clinical checkpoint falls
However, Soren Lontoft, pharma equity analyst at Sydbank, told CNBC last week that there was need for a diverse range of treatments to address both obesity and tolerability levels, as well as associated health risks like cardiovascular disease, sleep apnea and liver disease
The real key is pairing FDA-approved medications like Semaglutide or Tirzepatide with accountability, nutrition coaching, and a physician-supervised plan
More research is needed in this field